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Abstract
Objective To identify factors at 15 and 20 weeks’ gestation associated
with a subsequent uncomplicated pregnancy.
Design Prospective international multicentre observational cohort study.
Setting Auckland, New Zealand and Adelaide, Australia (exploration
and local replication dataset) and Manchester, Leeds, and London,
United Kingdom, and Cork, Republic of Ireland (external confirmation
dataset).
Participants 5628 healthy nulliparous women with a singleton
pregnancy.
Main outcome measure Uncomplicated pregnancy, defined as a
normotensive pregnancy delivered at >37 weeks’ gestation, resulting in
a liveborn baby not small for gestational age, and the absence of any
other significant pregnancy complications. In a stepwise logistic
regression the comparison group was women with a complicated
pregnancy.
Results Of the 5628 women, 3452 (61.3%) had an uncomplicated
pregnancy. Factors that reduced the likelihood of an uncomplicated
pregnancy included increased body mass index (relative risk 0.74, 95%
confidence intervals 0.65 to 0.84), misuse of drugs in the first trimester
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(0.90, 0.84 to 0.97), mean diastolic blood pressure (for each 5 mm Hg
increase 0.92, 0.91 to 0.94), and mean systolic blood pressure (for each
5 mm Hg increase 0.95, 0.94 to 0.96). Beneficial factors were
prepregnancy fruit intake at least three times daily (1.09, 1.01 to 1.18)
and being in paid employment (per eight hours’ increase 1.02, 1.01 to
1.04). Detrimental factors not amenable to alteration were a history of
hypertension while using oral contraception, socioeconomic index, family
history of any hypertensive complications in pregnancy, vaginal bleeding
during pregnancy, and increasing uterine artery resistance index.
Smoking in pregnancy was noted to be a detrimental factor in the initial
two datasets but did not remain in the final model.
Conclusions This study identified factors associated with normal
pregnancy through adoption of a novel hypothesis generating approach,
which has shifted the emphasis away from adverse outcomes towards
uncomplicated pregnancies. Although confirmation in other cohorts is
necessary, this study implies that individually targeted lifestyle
interventions (normalising maternal weight, increasing prepregnancy
fruit intake, reducing blood pressure, stopping misuse of drugs) may
increase the likelihood of normal pregnancy outcomes.
Trial registration Australian New Zealand Clinical Trials Registry
ACTRN12607000551493.
Introduction
Standard pathways of antenatal care have developed from the
perceived need to identify risk of adverse pregnancy
complications, enabling stratification of care and appropriate
targeting of prophylactic interventions. Comparatively little
effort has been made to recognise predictors of healthy
outcomes, although the concept of “health” is an increasingly
attractive addition to risk assessment.1 Indeed it is now suggested
that this concept be promoted and formulated as “the ability to
adapt and to self manage,”2 with the promotion of health
enabling empowerment of someone through lifestyle changes.
In its guidelines for antenatal care, the UK National Institute of
Health and Care Excellence states “The ethos of this guideline
is that pregnancy is a normal physiological process.”3 Promotion
of this concept of normality would be facilitated by identification
of those factors that make it more likely for a woman to have
an uncomplicated pregnancy.Women could thenmake informed
modifications to their lifestyle before or early in pregnancy, and
antenatal care could be tailored to deliver advice appropriately
in any resource setting.
In the United Kingdom, recent reports highlight the need to
improve stratification of risk, enabling women to be offered
midwifery led care if at low risk, or joint care with a specialist
when additional needs are identified. The Confidential Enquiry
into Maternal and Child Health reiterates the importance for
risk and needs assessment at the first antenatal visit to offer the
most appropriate care pathway and avoid those maternal deaths
associated with substandard practise arising from incorrect
assignment of risk.4To date, the majority of research has focused
on screening for pregnancy complications, such as
pre-eclampsia, gestational diabetes, and preterm birth. NICE
has identified the need for a validated assessment tool to predict
pregnancy outcomes.3
To inform development of a comprehensive assessment tool,
an understanding of the factors associated with subsequent
normal pregnancy provides a valuable aid to stratification.
Variables identified as being predictive of adverse outcomes
cannot automatically be adopted, through assumption of an
inverse relation, for identification of normal pregnancy.
We aimed to identify, replicate, and confirm variables at 15 and
20weeks’ gestation associated with a subsequent uncomplicated
pregnancy, and to highlight those factors amenable to
modification before pregnancy, to inform interventions that
could increase the likelihood of a normal outcome.
Methods
Between November 2004 and August 2008 we recruited
nulliparous womenwith singleton pregnancies to the Screening
for Pregnancy Endpoints (SCOPE) study, a prospective
observational multicentre cohort study in Auckland, New
Zealand; Adelaide, Australia; London, Manchester, and Leeds,
United Kingdom; and Cork, Republic of Ireland.5 All women
provided written informed consent.
We invited women before 15 weeks’ gestation and accessing
antenatal care through hospital antenatal clinics, obstetricians,
general practitioners, or community midwives to participate.
Exclusion criteria included a recognised high risk for
pre-eclampsia, delivery of a small for gestational age infant, or
spontaneous preterm birth due to underlying medical conditions
(chronic hypertension requiring antihypertensive drugs, diabetes,
renal disease, systemic lupus erythematosus, antiphospholipid
syndrome, sickle cell disease, HIV), previous cervical knife
cone biopsy, three or more terminations of pregnancy or three
ormoremiscarriages, current rupturedmembranes, knownmajor
fetal anomaly or abnormal karyotype, or an intervention that
might modify the pregnancy outcome (for example, aspirin,
cervical suture).5A research midwife interviewed and examined
participants at 14-16 and 19-21 weeks of gestation and the
women underwent ultrasonography at 19-21 weeks. At the time
of interview, data were entered into an internet accessed, central
database with a complete audit trail (MedSciNet, Stockholm,
Sweden).
At 14-16weeks’ gestationwe collected a comprehensive dataset:
personal information including socioeconomic index;
participant’s birth details; obstetric, gynaecological, andmedical
history; family history of obstetric complications and medical
conditions; early pregnancy complications; dietary information
before conception and during pregnancy (food frequency
questionnaire); and use of therapeutic medication and drugs of
misuse, cigarettes, and alcohol. Thewomen completed a lifestyle
questionnaire on work, exercise, and sedentary activities;
snoring; domestic violence; and social supports. Psychological
scales were completed measuring perceived stress,6 depression,7
anxiety,8 and behavioural responses to pregnancy (adapted from
the behavioural responses to illness questionnaire9). Maternal
measurements included blood pressure, height, weight andwaist,
hip, arm and head circumference, urinalysis, random blood
glucose levels, and ultrasound examination of the fetus and
uterine arteries at 19-21 weeks’ gestation. Full details of the
dataset have been previously described.10
We followed the participants prospectively, with pregnancy
outcome data and infant measurements collected by research
midwives. To minimise information bias, data monitoring
included an individual check of all data for each participant,
including a check for transcription errors of the lifestyle
questionnaire and ultrasound scan data; and detection of illogical
or inconsistent data and outliers using customised software.
Collection of outcome data aimed to be as comprehensive as
possible; we made multiple attempts to trace women with
missing data.
Primary outcome
The primary outcome was uncomplicated pregnancy, defined
as a normotensive pregnancy, delivered at >37 weeks, resulting
in a liveborn baby who was not small for gestational age, and
did not have any other significant pregnancy complications.We
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defined these pregnancy complications before the analysis. If
the pregnancy had been otherwise uneventful for those babies
who were admitted to the neonatal unit for transient observation,
we classified the pregnancy as uncomplicated.
Statistical analysis
Definition of datasets
We divided the dataset of 5628 women into three parts: an
exploration dataset of two thirds of the women from Australia
and New Zealand, chosen at random (n=2129); a local
replication dataset of the remaining third of women from
Australia and New Zealand (n=1067); and an external,
geographically distinct confirmation dataset of 2432 European
women from the United Kingdom and Republic of Ireland.
Selection of variables
The analysis strategy and variable selection was decided before
any statistical analysis. We carried out a detailed inspection of
the variables and rejected those that were not comparable across
different settings (for example, public or private maternity care
differed across the various settings; n=10), those that were not
measured in all women (for example, work related variables,
additional dietary questions; n=8), and those that were not
completed by at least 95% of women (for example, participant’s
birth weight; n=4). Where possible we used the variable based
on the response to the directly asked question; for those where
a large number of responses was possible (for example,
ethnicity), we used a derived variable based on clinically
relevant and generalisable collapsed groupings (for example,
white, non-white).
We selected a total of 86 variables, either based on directly
asked questions or derived as described, for further analysis, in
10 groups. Group 1 related to personal and family circumstances,
including ethnicity, personal characteristics, maternal birth
history, and obstetric history of relatives (16 predictors); group
2 related to general risk factors, including deprivation (eight
predictors); group 3 related to medical risk factors (19
predictors); group 4 related to obstetric history (six predictors);
group 5 related to minor early pregnancy complications (eight
predictors); group 6 related to diet (10 predictors, five relating
to prepregnancy period, five to pregnancy); group 7 related to
drug use (legal and illegal; six predictors); group 8 related to
physical examination (four predictors); group 9 related to current
workload and stress (six predictors); and group 10 related to the
20 week Doppler scan (10 predictors).
Variable reduction in the exploration dataset
The variable reduction process used the exploration dataset
only. Firstly, we discarded any potential predictor not
significantly (P<0.05) related to uncomplicated pregnancy by
simple t test or χ2 test. Using logistic regression, we found that
questions about diet from the pregnancy period were less useful
than questions about the month before pregnancy and so they
were also discarded. Secondly, we replaced categorical
predictors with more than two levels by a series of binary
indicator variables. For unordered variables, these weremutually
exclusive, but for ordered categories (time to conceive, vaginal
bleeding, diet, smoking, alcohol consumption, misuse of drugs,
moderate and vigorous physical activity), we set up indicator
variables so that with increasing exposure, more questions would
be answered as “yes.” For example, a former smoker who gave
up smoking during her pregnancy would be recorded as
“ever–yes,” “during pregnancy–yes,” and “currently–no.”With
this method, unlike the more usual dummy variables, combining
the categories by reducing the number of indicator variables
gave a simpler but coherent scale. The stepwise regression
automatically selected the best cut points.
During development of the model, we performed each analysis
on all available data without any imputation or recoding of
missing values. Thirdly, to further reduce the number of
predictors we fitted 10 backward stepwise logistic regression
models (P<0.05), one model for each of these 10 groups. The
key predictors that remained significant in the exploration
dataset were taken forward to the replication and confirmation
datasets.
Model local replication and external confirmation
We fitted the key predictor variables using unadjusted log
probability regression to the replication and confirmation
cohorts. The final list of consistent predictors was those that
remained significant in the external confirmation dataset. Final
results were presented as unadjusted risk ratios11 for a healthy
pregnancy outcome. The model for adjusted risk ratios failed
to converge (that is, no usable results were produced); with the
outcome having a prevalence of over 50% and strong predictor
variables, certain womenmight be given an impossible estimated
probability of over 100% when using adjusted risk ratios. For
presentation purposes in the final model, we split the
socioeconomic index into five groups at the quintiles, calculated
separately for each setting (Australasia versus United Kingdom
and Republic of Ireland). To give the risk ratio for clinically
relevant increments we rescaled continuous predictors: 5 mm
Hg systolic and diastolic blood pressure–5 mm Hg; uterine
artery resistance index–0.1; paid employment/week–eight hours;
we categorised body mass index using standard World Health
Organization thresholds of 25 and 30. For categorical variables
we chose the healthiest group to be the reference. For the
variables in the final model, data were available on 100% of
women apart from two variables; 19 (0.3%) values were missing
for hours worked in paid employment and 243 (4.3%) values
were missing for uterine artery Doppler resistance index.
Data analysis was conducted in Stata version 11.2.We estimated
risk ratios using binomial regression with a log link; using either
maximum qualified likelihood (Fisher scoring) or maximum
likelihood, depending on convergence.
The study has been reported in line with STROBE11
recommendations.
Results
Of the 5628 women, 3452 (61.3%) had an uncomplicated
pregnancy. Table 1⇓ shows the personal data and pregnancy
outcome characteristics for those women who had an
uncomplicated pregnancy and those with complications. A lower
proportion of women in the external confirmation dataset
(United Kingdom and Ireland) had an uncomplicated pregnancy
compared with women in Australasia (58.6% v 63.5%). Table
2⇓ gives the reasons for defining a pregnancy as complicated;
a woman could have several reasons. Table 3⇓ shows the
maternal and perinatal outcomes for the whole cohort.
Tables 4 and 5⇓⇓show the clinical variables associated with
subsequent uncomplicated pregnancy in univariable analysis.
All variables significantly associated with uncomplicated
pregnancy in the development dataset are shown; some variables
lost significance in the local replication and external
confirmation datasets. Table 6⇓ shows the variables that
remained after fitting the log probability regression model,
presented as unadjusted risk ratios (relating to risk of
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uncomplicated pregnancy). Factors amenable to improvement
that decreased the likelihood of an uncomplicated pregnancy
(that is, were detrimental) were increasing body mass index and
blood pressure and misuse of drugs (including binge alcohol
use) in the first trimester. Factors amenable to improvement
that increased the likelihood of an uncomplicated pregnancy
(that is, were beneficial) were high fruit intake in the month
before the pregnancy and being in paid employment at 15weeks’
gestation. Smoking in pregnancy was noted to be detrimental
and leafy vegetable intake was beneficial for subsequent
uncomplicated pregnancy in the initial two datasets, but neither
variable remained in the final model. Factors not amenable to
alteration that reduced the likelihood of an uncomplicated
pregnancy were being in a lower fifth of socioeconomic index,
the presence of hypertension before pregnancy while using oral
contraceptive pills, family history of any hypertensive disorder
in pregnancy, and vaginal bleeding during pregnancy.
Addition of ultrasound indices from the 20 week examination
to the model resulted in one additional non-modifiable variable
reducing the likelihood of an uncomplicated pregnancy: raised
mean uterine artery resistance index.
Discussion
In our large prospective international cohort of healthy
nulliparous women we identified factors related to maternal
weight, diet, blood pressure (within the normal range), and
misuse of drugs that are potentially amenable to modification
before pregnancy and could result in uncomplicated pregnancy
outcomes. We recognise that identification of risk factors does
not equate to utility for prediction (for example, through a risk
algorithm), nor does it assume that modification would
inevitably lead to improved outcomes. However, if confirmed
in a further external dataset, knowledge of these factors could
inform women, their healthcare providers, and policy makers
on variables that could be targeted for change on an evidence
based foundation, and inform future intervention trials.
To our knowledge this is the first study to comprehensively
investigate and identify factors present early in pregnancy that
are associated with an uncomplicated outcome. Although several
variables have been shown to be associated with adverse
pregnancy events,10 12 few studies have focused on normality as
the outcome. The WHO recently reiterated the importance of
Millennium Development goal 5 by promotion of universal
access to reproductive health, in tandemwith reducing maternal
mortality.13
Strengths and weaknesses of this study
A major strength of this study is that we collected all data
prospectively, from multiple centres in an international setting.
The interviews were conducted by research midwives using a
real-time internet database, automated data queries, and detailed
standard operating procedures, which ensured high quality data
with a high rate of follow-up and complete datasets. The
research midwives collected all outcome data and these were
reviewed by a principal investigator, avoiding the assignment
errors associated with using routine hospital coding. The number
of variables collected in our study enabled a comprehensive
assessment of factors to be considered; while confounding can
never be avoided completely, this was reduced by inclusion of
terms for all major explanatory variables. Exploration of
variables in the development dataset was followed by replication
and confirmation in two other datasets, one local and one
external, increasing the robustness of the associations and the
generalisability of the results. The variables in the final model
are consistent with biological plausibility, but the predictive
nature of these variables requires validation in future studies.
The study invited nulliparous women with no major medical
conditions to participate, in order to assist in identification of
risk factors without the additional complexities of pre-existing
medical conditions. This enables the findings to be generalised
to other similar populations of pregnant women but not
automatically to other groups (nulliparous women with medical
disorders or multiparous women). It is also possible that the
method of variable selection could have omitted some predictive
factors in favour of others that are even more useful, and
therefore the list of variables identified is not all inclusive.
However, the resulting list is intended to be both generally
applicable and of a manageable size.
Comparisons with other studies
Many studies have investigated factors, often in relative isolation
from confounders, and usually in association with adverse
pregnancy outcome. We are not aware of any studies using a
similar approach to that employed in the present study. Previous
evidence of an association between a factor and adverse outcome
cannot be extrapolated to indicate that the same variable reduces
the likelihood of an uncomplicated pregnancy, but it may support
biological plausibility. For example, (lower) maternal age was
not included in the final list of variables associated with
uncomplicated pregnancy in our study, despite many studies
linking advanced maternal age to adverse pregnancy
outcomes.14 15 Although it might seem intuitive that improvable
factors related to diet, blood pressure, heart rate, weight, and
smoking would predict uncomplicated pregnancy, the evidence
fromwell conducted prospective cohort studies has been lacking
to date.
The association between obesity and adverse perinatal outcome
has been well documented; obesity is strongly associated with
an increased risk of maternal and fetal morbidity and mortality,
including pre-eclampsia, gestational diabetes, thromboembolic
disease, maternal mortality, congenital malformations,
macrosomia, perinatal mortality, and subsequent adult
cardiovascular disease for the infant.16 In our study, with
confounding variables included in the model, overweight and
obese women were less likely to have an uncomplicated
pregnancy outcomewhen compared to those with a normal body
mass index. We also found an inverse relation between blood
pressure and uncomplicated pregnancy outcome. The majority
of relevant studies relating blood pressure to pregnancy outcome
have focused on the relation between high blood pressure and
adverse outcomes. In a systematic review, significantly increased
odds ratios for subsequent pre-eclampsia were found for systolic
blood pressure >130 mm Hg and diastolic blood pressure >80
mm Hg, compared with women with blood pressures below
those thresholds.17 Even in womenwith subsequent normal term
pregnancy, established pre-eclampsia risk factors (for example,
obesity, nulliparity) are associated with higher blood pressure
in early pregnancy, suggesting that risk relates to a continuum
rather than to a threshold.18
Our study also shows that a high fruit intake before pregnancy
increases the likelihood of a normal pregnancy outcome.
Previous reports have shown high fruit and vegetable intake in
pregnancy to be associated with a decreased risk of
pre-eclampsia19 and preterm birth20 and increased infant birth
weight (by 10.7 g, 95% confidence interval 7.3 to 14.2g per
quintile).21 Women in Scotland from the most deprived 10th of
the population with a diet lower in fruit and vegetable intake
(and higher in processed food and other less healthy foods) had
poorer perinatal outcomes than those in less deprived 10ths; the
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authors speculated that improving the nutrient intake of such
women may improve pregnancy outcomes.22 In a study from
England, only 53% of women of reproductive age said that they
followed the recommendation to consume five or more portions
of fruit and vegetables daily,23 but our study suggests that
preparation for pregnancy should include advice to increase
fruit intake.
Illicit drug use24 and binge alcohol drinking25 have an association
with adverse pregnancy outcomes and thus it is not surprising
that in our study their use decreased the likelihood of an
uncomplicated pregnancy. Rates of drug misuse in the first
trimester (which included binge alcohol) were high, particularly
in the United Kingdom and Republic of Ireland cohort but not
inconsistent with estimates of binge drinking and illicit drug
use in women of reproductive age.26 The finding that paid
employment is associated with an improved likelihood of
uncomplicated pregnancy has been described previously,27 28
but there may well be confounding factors (even after
adjustment) that account for some of this effect.
Identification of non-modifiable factors is useful for future
research into prediction and generating hypotheses for
understanding possible causation. Here we have identified that
a history of hypertension with previous use of oral
contraceptives was associated with a reduced likelihood of
normal pregnancy outcome.Women who become hypertensive
while using the oral contraceptive pill may have underlying
cardiovascular risk factors that increase their predisposition to
hypertension both while using the contraceptive pill and while
pregnant.
The socioeconomic index is influenced by many factors, and
its pivotal role in determining health has been recognised by
the recent strategic review of health inequalities led byMarmot29;
of the six policy objectives presented, the highest
recommendation was to “Give every child the best start in life,”
through “Giving priority to prenatal interventions that reduce
adverse outcomes of pregnancy and infancy” and other postnatal
strategies. For outcomes such as neonatal mortality, much of
the gap between the most deprived 10th of the population and
the least deprived could be explained by premature birth and
congenital anomalies, suggesting a focus for future specific
intervention30: a similar deprivation gap exists for stillbirths,31
but there is little evidence on strategies that promote healthy
pregnancy outcomes.
We have also observed that vaginal bleeding in early pregnancy
significantly reduced the odds of an uncomplicated pregnancy.
Several large systematic reviews all concur that vaginal bleeding
increases the risk of subsequent pregnancy complications.32 33
The finding of an increased uterine artery resistance index (with
higher levels more abnormal) being associated with a reduced
likelihood of uncomplicated pregnancy is in keeping with the
conclusions from the largest systematic review and
meta-analysis of uterine artery Doppler ultrasonography. In low
risk women an abnormal uterine artery Doppler waveform was
predictive of pre-eclampsia (positive likelihood ratio 7.5, 95%
confidence interval 5.4 to 10.2; negative likelihood ratio 0.59,
95% confidence interval 0.47 to 0.71) and fetal growth
restriction (positive likelihood ratio 9.1, 95% confidence interval
5.0 to 16.7; negative likelihood ratio 0.89, 95% confidence
interval 0.85 to 0.93).34
Clinical relevance
This study has identified factors that are potentially amenable
to alteration, especially if implemented before pregnancy, and
which, if improved, may improve the likelihood of an
uncomplicated pregnancy. An understanding of both these and
the non-modifiable factors associated with uncomplicated
pregnancy provide potential to assist public health strategies
and inform family doctors and maternal care providers when
advising women planning a future pregnancy. The findings
should be generalisable to other nulliparous women in high
income settings; the full description of their personal
characteristics and outcomes should enable comparison with
other populations. Smoking in pregnancy was noted to be
detrimental in the first two datasets and the association between
smoking and subsequent adverse outcome is well recognised35;
recommendations for smoking cessation before and in pregnancy
continue to be important in preventing infant morbidity and
mortality.
Evidence based recommendations for lifestyle management
already exist for non-hypertensive people to optimise their blood
pressure through physical exercise, weight reduction, limiting
sodium intake and alcohol consumption, and consuming a
healthy diet.36Our study suggests that adoption of these choices
seems to be beneficial in determining subsequent uncomplicated
pregnancy. To illustrate the possible benefits a 5 mm Hg
reduction of maternal systolic blood pressure (relative risk 0.95,
table 5) would increase the proportion of uncomplicated
pregnancies by 3.1% from 58.6% to 61.7%. Among 800 000
live births (the approximate annual number in the United
Kingdom), this would equate to 24 674 more women having an
uncomplicated pregnancy. A systolic blood pressure reduction
of this magnitude is comparable to that reported for interventions
such as improved diet and exercise in a recent systematic
review.37 If it were achieved through lifestyle interventions to
produce fitter, healthier women of reproductive age with lower
blood pressure, there would be likely additional benefits (for
example, on body mass index and glucose metabolism) that are
difficult to quantify. The magnitude of benefit achievable by
these interventions would none the less require demonstration
in a well designed epidemiological cohort study or a randomised
controlled trial. Health promotion interventions are of relevance
to policy makers in the public health arena and all health
professionals involved in the promotion of prepregnancy
lifestyle.
Unanswered questions and future research
Although this study has elucidated associations between certain
variables and uncomplicated pregnancy outcome, further
investigations are required to determine whether these have
causal importance. These factors could be incorporated into a
predictive algorithm for evaluation in a larger cohort to identify
women who are likely to have an uncomplicated pregnancy;
antenatal care could be tailored to such risk stratification. The
few studies that have examined health promotion interventions
specifically to modify risk factors before pregnancy were varied,
and follow-up of pregnancy outcome was of mixed quality
leading the authors of a systematic review to recommend that
more research was needed.38 Considerable effort would be
required to determine, through a theoretically based approach,
the most effective means of delivery of the interventions to
women of reproductive age and in pregnancy to assess whether
the targeted behaviours change as anticipated and to determine
whether these relate to improved pregnancy outcome.
Conclusions
There is growing interest in promotion of health and normality,
rather than an exclusive focus on adverse outcomes. Based on
a large prospective cohort study of healthy nulliparous women,
we identified, replicated, and externally confirmed improvable
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2013;347:f6398 doi: 10.1136/bmj.f6398 (Published 21 November 2013) Page 5 of 13
RESEARCH
factors associated with uncomplicated pregnancy; these related
to optimising weight, diet, cardiovascular fitness, and cessation
of illicit drug use. Providing confirmation is forthcoming from
other cohorts, this study should inform development of
interventions to increase normal pregnancy outcomes.
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What is already known on this topic
Previous literature has focused on the association between risk factors and subsequent adverse pregnancy outcomes
Little is known of factors associated with subsequent healthy pregnancies
What this study adds
Factors associated with subsequent uncomplicated pregnancy amenable to alteration include normalising maternal weight, increasing
prepregnancy fruit intake, reducing blood pressure, stopping misuse of drugs (including binge alcohol use), and being in paid employment
Identification of these factors could inform development of interventions to increase normal pregnancy outcomes
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Tables
Table 1| Maternal characteristics at first visit (15 weeks’ gestation). Values are numbers (percentages) unless stated otherwise
External confirmation dataset (n=2432)Local replication dataset (n=1067)Development dataset (n=2129)
Characteristics ComplicatedUncomplicatedComplicatedUncomplicatedComplicatedUncomplicated
1008 (41)1424 (59)390 (37)677 (63)778 (36)1351 (64)Total
29.3 (5.0)29.7 (4.8)27.6 (6.1)28.2 (5.8)27.7 (6.0)28.2 (5.7)Mean (SD) maternal age
(years)
950 (94)1337 (94)337 (86)587 (87)667 (86)1183 (88)White ethnicity
262 (26)294 (21)206 (53)324 (48)404 (52)634 (47)<12 years schooling
59 (5.9)74 (5.2)44 (11)57 (8.4)96 (12)97 (7.0)Unemployed
138 (14)153 (11)32 (8.2)51 (7.5)68 (8.7)98 (7.3)Single
267 (26)337 (24)150 (39)267 (39)310 (40)459 (34)In relationship (unmarried)
603 (60)934 (65)208 (53)359 (53)400 (51)794 (59)Married
796 (79)1165 (82)288 (74)497 (73)558 (72)1027 (76)Primigravid
150 (15)185 (13)57 (15)97 (14)119 (15)167 (12)Previous miscarriage
68 (6.7)83 (5.8)52 (13)100 (15)112 (14)182 (14)Previous abortion
717 (71)1053 (74)281 (72)538 (80)596 (77)1078 (80)No smoking in pregnancy
175 (17)237 (17)50 (13)69 (10)73 (9.4)154 (11)Quit smoking in pregnancy
116 (12)134 (9)59 (15)70 (10)109 (14)119 (8.8)Smoking at first visit
218 (22)314 (22)205 (52)349 (52)426 (54)679 (51)No alcohol in pregnancy
621 (61)861 (61)171 (44)293 (43)307 (40)612 (45)Quit alcohol in pregnancy
169 (17)249 (17)14 (3.6)35 (5.2)45 (5.8)60 (4.4)Continuing to drink alcohol at
15 weeks
466 (46)574 (40)65 (17)96 (14)127 (16)165 (12)Misuse of drugs in first
trimester*
Body mass index:
10 (1.0)18 (1.2)7 (1.9)13 (1.9)15 (1.9)21 (1.6)<18.5
528 (52)897 (63)174 (44)411 (61)342 (44)771 (57)18.5-24.9
309 (30)370 (26)109 (28)166 (24)237 (30)385 (28)25-29.9
161 (16)139 (9)100 (25)87 (13)184 (24)174 (13)≥30
Mean (SD) blood pressure (mm
Hg):
107 (11)104 (10)110 (10)106 (10)110 (11)107 (9)Systolic
67 (8)65 (7)66 (8)64 (8)67 (9)64 (7)Diastolic
See table 2 for reasons pregnancy was considered complicated.
*Use of marijuana, cocaine/crack, amphetamines, 3,4 methylenedioxymethamphetamine, opiates, hallucinogens, and binge alcohol ≥6 units/session.
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Table 2| Reasons for complicated pregnancy (non-exclusive) in 5628 women







238 (9.8)75 (7.0)158 (7.4)Gestational hypertension
100 (4.1)67 (6.3)113 (5.3)Pre-eclampsia
6 (0.3)13 (1.2)18 (0.8)Gestational proteinuria
54 (2.2)26 (2.4)65 (3.1)Gestational diabetes
245 (10)63 (5.9)124 (5.9)Antepartum haemorrhage, placenta praevia, or
placenta accreta
16 (0.7)7 (0.7)17 (0.8)Placental abruption
6 (0.3)1 (0.1)10 (0.5)Chronic hypertension (mild, diagnosed in pregnancy)
17 (0.7)9 (0.8)16 (0.8)Renal tract complications*
12 (0.5)4 (0.4)8 (0.4)Gastrointestinal tract or hepatic complications
7 (0.3)6 (0.6)8 (0.4)Respiratory complications†
80 (3.3)22 (2.1)45 (2.1)Other obstetric complications‡
41 (1.7)11 (1.0)17 (0.8)Other medical complications§
001 (0.1)Maternal death during pregnancy
Fetal complications:
291 (12)115 (11)227 (11)Small for gestational age infant (<10th customised
birthweight centile)
79 (3.3)50 (4.7)104 (4.9)Spontaneous preterm birth
65 (2.7)24 (2.2)58 (2.7)Other fetal problems (including severe neonatal
morbidity¶
51 (2.1)27 (2.5)54 (2.5)Fetal anomalies
15 (0.6)8 (0.7)22 (1.0)Fetal death in utero ≥20/40 or neonatal death
10 (0.4)3 (0.3)11 (1.4)Fetal death in utero <20/40
4 (0.3)5 (0.5)9 (0.4)Miscarriage or abortion <20/40
*For example, pyelonephritis.
†For example, pneumonia.
‡Obstetric cholestasis, sustained gestational thrombocytopenia, cervical cerclage, oligohydramnios, polyhydramnios, chorioamnionitis, surgery in pregnancy,
admitted to hospital for threatened preterm labour but delivered at term, genital tract problems, major postpartum complications.
§Venous thromboembolism; neurological, haematological and cardiac conditions; other medical conditions leading to hospital admission.
¶Grade II or III hypoxic ischaemic encephalopathy; ventilation >24 hours; neonatal unit admission >4 days; Apgar score <4 at five minutes; cord arterial pH <7.0
or base excess ≥15, or both; or neonatal seizures.
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Table 3| Maternal and perinatal outcomes. Values are numbers (percentages) unless stated otherwise















Mean (SD) blood pressure
(mm Hg):
132 (25)121 (27)130 (25)120 (11)130 (25)120 (11)Systolic
84 (18)76 (20)80 (18)73 (8)80 (18)73 (8)Diastolic
39.1 (3.0)40.3 (1.1)38.3 (4.0)40.0 (1.2)38.2 (4.1)40.1 (1.2)Mean (SD) gestation at
delivery (weeks)
423 (42)562 (40)158 (41)363 (54)344 (44)684 (51)Unassisted vaginal delivery
312 (31)517 (36)74 (19)147 (22)139 (18)293 (22)Operative vaginal delivery
121 (12)126 (8.8)52 (13)44 (6.5)79 (10)76 (5.6)Prelabour caesarean section
147 (15)218 (15)101 (26)123 (18)206 (27)298 (22)Caesarean section in labour
Perinatal outcomes
3169 (708)3582 (408)3015 (797)3548 (401)3030 (823)3586 (416)Mean (SD) infant birth weight
(g)
32 (8 to 64)52 (31 to 76)29 (7 to 60)51 (30 to 74)32 (9 to 69)54 (33 to 75)Median (interquartile range)
customised centile
201 (20)67 (4.7)96 (25)19 (2.8)203 (26)61 (4.5)Admission to neonatal unit
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Table 4| Unadjusted comparisons on all variables in development and local replication datasets. Unless stated otherwise all parameters
relate to first visit at 15 weeks’ gestation, and results are numbers (percentages)
Local replication dataset (n=1067)Development dataset (n=2129)
Variables













Decreased risk of uncomplicated
pregnancy:
−2.0 (−2.7 to −1.2)26.9 (6.5)24.9 (4.9)−1.7 (–2.2 to −1.3)26.7 (5.9)25.0 (4.5)Mean (SD) body mass index
Mean blood pressure (mm Hg):
−4 (−5 to −3)110 (10)106 (10)−4 (−5 to −3)111 (11)107 (10)Systolic
−3 (−4 to −2)66 (8)64 (8)−3 (−4 to −2)67 (9)64 (7)Diastolic
−4 (−5 to −2)80 (11)76 (11)−3 (−4 to −2)79 (11)76 (11)Mean (SD) maternal pulse
0.84 (0.71 to 0.99)59 (15)70 (10)0.81 (0.71 to 0.92)109 (14)119 (9)Current smoking
1.01 (0.93 to 1.11)185 (47)328 (48)1.07 (1.00 to 1.14)352 (45)672 (50)Any alcohol use in pregnancy
0.93 (0.81 to 1.07)65 (17)96 (14)0.86 (0.78 to 0.96)127 (16)161 (12)Misuse of drugs in first trimester*
0.90 (0.76 to 1.07)44 (11)60 (9)0.77 (0.67 to 0.89)102 (13)103 (8)Unemployed or sickness
beneficiary
Increased risk of uncomplicated
pregnancy:
Prepregnancy intake:
1.12 (0.94 to 1.33)346 (89)618 (91)1.35 (1.17 to 1.55)635 (85)1241 (92)Fruit ≥1-2/week
1.25 (1.14 to 1.36)62 (16)184 (27)1.19 (1.11 to 1.27)124 (17)337 (25)Fruit ≥3-4/day
1.20 (1.10 to 1.32)159 (41)362 (54)1.17 (1.09 to 1.24)321 (43)718 (53)Leafy vegetables ≥1-2/day
1.7 (-0.4 to 3.8)30.5 (17.0)32.2 (16.4)2.5 (1.0 to 4.0)29.7 (17.3)32.3 (15.8)Mean (SD) hours worked in paid
employment/week
Non-modifiable factors
Decreased risk of uncomplicated
pregnancy:
0.80 (0.62 to 1.04)28 (7)30 (5)0.79 (0.66 to 0.95)56 (7)59 (4)Participant was born preterm
2 (0 to 4)39 (16)41 (16)3 (2 to 5)39 (17)42 (17)Mean (SD) lower socioeconomic
index
0.58 (0.32 to 1.04)12 (3)7 (1)0.59 (0.39 to 0.90)23 (3)14 (1)Hypertension during oral
contraceptive pill use before
pregnancy
0.91 (0.83 to 1.00)166 (43)247 (37)0.90 (0.84 to 0.97)312 (40)458 (34)Duration of sex without
contraception before pregnancy
≥3 months
0.84 (0.74 to 0.96)97 (25)120 (18)0.87 (0.80 to 0.96)184 (23.9)243 (18)Family history of any hypertensive
complications in pregnancy
0.83 (0.70 to 0.98)57 (15)66 (10)0.86 (0.77 to 0.96)134 (17)168 (12)Family history of any diabetes
0.88 (0.72 to 1.09)30 (8)39 (6)0.78 (0.65 to 0.94)57 (7)57 (4)Gastroenteritis during pregnancy
0.88 (0.78 to 0.99)101 (26)135 (20)0.88 (0.81 to 0.96)187 (24)251 (19)Vaginal bleeding (more than
spotting <15 weeks)
0.90 (0.76 to 1.06)46 (12)62 (9)0.82 (0.73 to 0.93)114 (15)130 (10)Currently using β2 agonist inhaler
0.63 (0.40 to 1.00)16 (4)11 (2)0.62 (0.44 to 0.87)30 (4)20 (2)Fetal abnormality present (20
weeks)
−0.03 (−0.04 to −0.01)0.58 (0.10)0.56 (0.09)−0.03 (−0.04 to −0.02)0.58 (0.10)0.55 (0.09)Mean (SD) uterine artery
resistance index (20 weeks)
Increased risk of uncomplicated
pregnancy:
0.99 (0.90 to 1.10)288 (74)497 (73)1.09 (1.01 to 1.18)558 (72)1027 (76)Primigravid
1.10 (0.99 to 1.21)80 (21)169 (25)1.13 (1.05 to 1.21)152 (20)342 (26)Immigrant partner
*Use of marijuana, cocaine/crack, amphetamines, 3,4 methylenedioxymethamphetamine, opiates, hallucinogens, and binge alcohol ≥6 units/session.
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Table 5| Unadjusted comparisons on all variables in external confirmation dataset. Unless stated otherwise all parameters relate to first
visit at 15 weeks’ gestation, and results are numbers (percentages)
External confirmation dataset (n=2432)
Variables Risk ratio or mean differenceComplicated (n=1008)Uncomplicated (n=1424)
Potentially improvable factors
Decreased risk of uncomplicated pregnancy:
−1.14 (−1.50 to −0.78)25.6 (4.8)24.4 (3.9)Mean (SD) body mass index
Mean blood pressure (mm Hg):
−3 (−4 to −2)107 (11)104 (10)Systolic
−2 (−3 to −2)67 (8)65 (7)Diastolic
−1 (−1 to 0)78 (10)77 (10)Mean (SD) maternal pulse
0.91 (0.80 to 1.02)116 (12)134 (9)Current smoking
0.99 (0.91 to 1.07)790 (78)1110 (78)Any alcohol use in pregnancy
0.90 (0.84 to 0.97)466 (46)574 (40)Misuse of drugs in first trimester*
0.90 (0.77 to 1.05)71 (7)80 (6)Unemployed or sickness beneficiary
Increased risk of uncomplicated pregnancy:
Prepregnancy intake:
1.11 (0.96 to 1.29)928 (92)1334 (94)Fruit ≥1-2/week
1.09 (1.01 to 1.18)205 (20)343 (24)Fruit ≥3-4/day
1.06 (0.98 to 1.15)184 (18)294 (21)Leafy vegetables ≥1-2/day
1.3 (0.1 to 2.4)32.4 (14.5)33.8 (13.8)Mean (SD) hours worked in paid employment/week
Non-modifiable factors
Decreased risk of uncomplicated pregnancy:
1.02 (0.85 to 1.21)35 (4)52 (4)Participant was born preterm
3 (1 to 4)42 (16)45 (17)Mean (SD) lower socioeconomic index
0.47 (0.26 to 0.85)21 (2)8 (1)Hypertension during oral contraceptive pill use before
pregnancy
1.00 (0.94 to 1.07)393 (39)559 (39)Duration of sex without contraception before pregnancy ≥3
months
0.87 (0.79 to 0.97)196 (19)215 (15)Family history of any hypertensive complications in
pregnancy
0.97 (0.88 to 1.08)144 (14)193 (14)Family history of any diabetes
0.86 (0.68 to 1.09)35 (4)36 (3)Gastroenteritis during pregnancy
0.88 (0.81 to 0.96)251 (25)282 (20)Vaginal bleeding (more than spotting <15 weeks)
0.90 (0.77 to 1.06)66 (7)75 (5)Currently using β2 agonist inhaler
0.97 (0.67 to 1.41)9 (1)12 (1)Fetal abnormality present (20 weeks)
−0.02 (−0.02 to −0.01)0.58 (0.11)0.57 (0.10)Mean (SD) uterine artery resistance index (20 weeks)
Increased risk of uncomplicated pregnancy:
1.08 (0.99 to 1.18)796 (79)1165 (82)Primigravid
1.00 (0.92 to 1.08)197 (20)277 (20)Immigrant partner
*Use of marijuana, cocaine/crack, amphetamines, 3,4 methylenedioxymethamphetamine, opiates, hallucinogens, and binge alcohol ≥6 units/session.
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Table 6| Unadjusted risk ratios for variables associated with subsequent uncomplicated pregnancy remaining significant in log probability
regression model







Decreased risk of uncomplicated
pregnancy/detrimental:
Body mass index at 15 weeks’ gestation:
0.74 (0.65 to 0.84)0.66 (0.56 to 0.78)0.71 (0.63 to 0.79)≥30 (v <25)
0.87 (0.80 to 0.94)0.86 (0.77 to 0.96)0.90 (0.83 to 0.97)25-29.9 (v <25)
Mean blood pressure (per 5 mmHg increase) at 15
weeks’ gestation:
0.92 (0.91 to 0.94)0.93 (0.91 to 0.96)0.93 (0.91 to 0.94)Diastolic
0.95 (0.94 to 0.96)0.94 (0.93 to 0.95)0.94 (0.93 to 0.96)Systolic
0.90 (0.84 to 0.97)0.93 (0.81 to 1.07)0.86 (0.78 to 0.96)Misuse of drugs in first trimester*
Increased risk of uncomplicated pregnancy/ beneficial:
1.09 (1.01 to 1.18)1.25 (1.14 to 1.36)1.19 (1.11 to 1.27)Prepregnancy fruit intake at least 3 times/day
1.02 (1.01 to 1.04)1.02 (1.00 to 1.04)1.03 (1.01 to 1.04)Hours worked in paid employment (per 8 hours
increase) at 15 weeks’ gestation
Non-modifiable
Decreased risk of uncomplicated
pregnancy/detrimental:
Maternal socioeconomic index at 15 weeks’ gestation:
0.83 (0.74 to 0.92)0.95 (0.81 to 1.11)0.84 (0.75 to 0.93)1st (bottom) fifth (v 5th (top) fifth):
0.88 (0.80 to 0.98)0.91 (0.77 to 1.07)0.86 (0.77 to 0.96)2nd fifth (v top fifth)
0.88 (0.79 to 0.97)1.07 (0.92 to 1.23)0.97 (0.88 to 1.06)3rd fifth (v top fifth)
0.93 (0.85 to 1.03)1.06 (0.92 to 1.23)1.02 (0.93 to 1.12)4th fifth (v top fifth)
0.47 (0.26 to 0.85)0.58 (0.32 to 1.04)0.59 (0.39 to 0.90)Hypertension with oral contraceptive pill use before
pregnancy
0.87 (0.79 to 0.97)0.84 (0.74 to 0.96)0.87 (0.80 to 0.96)Family history of any hypertensive disorder in
pregnancy
0.88 (0.81 to 0.96)0.88 (0.78 to 0.99)0.88 (0.81 to 0.96)Vaginal bleeding (more than spotting) in pregnancy
before 15 weeks’ gestation
0.95 (0.92 to 0.98)0.91 (0.87 to 0.95)0.91 (0.88 to 0.94)Mean uterine artery resistance index (per 0.1 increase)
at 20 weeks’ gestation
*Use of marijuana, cocaine/crack, amphetamines, 3,4 methylenedioxymethamphetamine, opiates, hallucinogens, and binge alcohol ≥6 units/session.
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